Get Level 2
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. ABD.L Share Price
  4. ABD.L Share Regulatory News
  5. Update research from QuotedData

Pin to quick picksABD.L Regulatory News (ABD)

ABD.L Information
  • There is currently no data for ABD

Update research from QuotedData

9 Nov 2021 13:47

RNS Number : 7962R
Aberdeen New Dawn Invest Trust PLC
09 November 2021
 

Aberdeen New Dawn Investment Trust - Update research from QuotedData

4th November 2021

 

Caution wins out in the end

 

 

After another challenging six months since our last note, with initially unscathed Asia finally being hit hard by COVID-19, Aberdeen New Dawn (ABD) has maintained its strong performance, showing it can still be resilient in falling markets.

 

 

Full research:

https://quoteddata.com/research/aberdeen-dawn-caution-wins-qd/ 

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

 

NB: Marten & Co was paid to produce this note on Aberdeen New Dawn Investment Trust Plc and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the FCA. Marten & Co is not permitted to provide investment advice to individual investors.

 

QUOTEDDATA123a Kings Road | London SW3 4PLTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUKRRRARUARAA
34567891011
Date   Source Headline
27th Feb 20232:04 pmRNSGearing disclosure
27th Feb 202312:35 pmRNSNet Asset Value(s)
24th Feb 20235:23 pmRNSTransaction in Own Shares
24th Feb 20231:32 pmRNSNet Asset Value(s)
23rd Feb 20235:25 pmRNSTransaction in Own Shares
23rd Feb 202311:41 amRNSNet Asset Value(s)
22nd Feb 202311:37 amRNSNet Asset Value(s)
21st Feb 202310:59 amRNSNet Asset Value(s)
20th Feb 20231:35 pmRNSGearing disclosure
20th Feb 202312:37 pmRNSNet Asset Value(s)
17th Feb 20235:04 pmRNSTransaction in Own Shares
17th Feb 202312:34 pmRNSNet Asset Value(s)
16th Feb 20235:05 pmRNSTransaction in Own Shares
16th Feb 202312:07 pmRNSNet Asset Value(s)
15th Feb 20235:07 pmRNSTransaction in Own Shares
15th Feb 202311:31 amRNSNet Asset Value(s)
14th Feb 20235:16 pmRNSTransaction in Own Shares
14th Feb 20234:07 pmRNSPortfolio disclosure
14th Feb 202312:28 pmRNSNet Asset Value(s)
14th Feb 20238:42 amRNSUpdate research from QuotedData
13th Feb 20234:59 pmRNSTransaction in Own Shares
13th Feb 20233:48 pmRNSGearing disclosure
13th Feb 202312:30 pmRNSNet Asset Value(s)
10th Feb 202312:41 pmRNSNet Asset Value(s)
9th Feb 20235:23 pmRNSTransaction in Own Shares
9th Feb 20231:05 pmRNSNet Asset Value(s)
8th Feb 20231:24 pmRNSNet Asset Value(s)
7th Feb 20235:11 pmRNSTransaction in Own Shares
7th Feb 20231:29 pmRNSNet Asset Value(s)
6th Feb 20234:03 pmRNSMonth End Net Asset Value(s)
6th Feb 20232:42 pmRNSGearing Disclosures
6th Feb 202312:09 pmRNSNet Asset Value(s)
3rd Feb 202312:23 pmRNSNet Asset Value(s)
2nd Feb 20235:04 pmRNSTransaction in Own Shares
2nd Feb 20233:57 pmRNSQuarterly disclosure
2nd Feb 20231:01 pmRNSNet Asset Value(s)
1st Feb 20235:20 pmRNSTransaction in Own Shares
1st Feb 202310:40 amRNSTotal Voting Rights
1st Feb 202310:11 amRNSBlock listing Interim Review
31st Jan 202312:34 pmRNSNet Asset Value(s)
30th Jan 20232:10 pmRNSGearing disclosure
30th Jan 202312:31 pmRNSNet Asset Value(s)
27th Jan 202312:09 pmRNSNet Asset Value(s)
26th Jan 202312:00 pmRNSNet Asset Value(s)
25th Jan 202312:32 pmRNSNet Asset Value(s)
24th Jan 202312:58 pmRNSNet Asset Value(s)
23rd Jan 20234:22 pmRNSGearing disclosure
23rd Jan 202312:35 pmRNSNet Asset Value(s)
20th Jan 202312:48 pmRNSNet Asset Value(s)
19th Jan 20235:11 pmRNSTransaction in Own Shares
34567891011

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
2LU9
Citi Fun 27
LSE
0.00%
2LZ0
Citi Fun 27
LSE
0.00%
2OJ0
Citi Fun 28
LSE
0.00%
1SN9
Citi Fun 27
LSE
0.00%
1SM4
Citi Fun 27
LSE
0.00%
Trending
NANO
Nanoco
LSE
17.93%
GST
GSTechnologies
LSE
-4.82%
QHE
Quantum Helium
LSE
9.93%
KEFI
Kefi Gold & Copper
LSE
1.40%
ALRT
Defence Holdings
LSE
-11.76%